The Multiple Therapeutic Targets of A20 de Christiane Ferran

The Multiple Therapeutic Targets of A20: Advances in Experimental Medicine and Biology, cartea 809

Christiane Ferran

en Limba Engleză Paperback – 27 aug 2016

This book is meant to provide the most current knowledge regarding the mechanisms of action of A20, if its versatile functions and their validation in animal models of human disease and its promise as a diagnostic biomarker and therapeutic target.

Citește tot Restrânge

Toate formatele și edițiile

	Preț	Express
Paperback (1)	1089^.68 lei 6-8 săpt.
Springer – 27 aug 2016	1089^.68 lei 6-8 săpt.
Hardback (1)	1099^.35 lei 3-5 săpt.
Springer – 6 feb 2014	1099^.35 lei 3-5 săpt.

Din seria Advances in Experimental Medicine and Biology

9%

Preț: 719^.56 lei
5%

Preț: 717^.20 lei
20%

Preț: 691^.93 lei
5%

Preț: 715^.71 lei
5%

Preț: 1113^.83 lei
5%

Preț: 1031^.00 lei
15%

Preț: 640^.24 lei
5%

Preț: 717^.00 lei
5%

Preț: 820^.42 lei
5%

Preț: 717^.00 lei
5%

Preț: 715^.35 lei
5%

Preț: 716^.28 lei
5%

Preț: 716^.28 lei
15%

Preț: 641^.38 lei
20%

Preț: 1161^.71 lei
5%

Preț: 1170^.51 lei
18%

Preț: 1119^.87 lei
5%

Preț: 1288^.48 lei
5%

Preț: 1164^.67 lei
5%

Preț: 1101^.73 lei
18%

Preț: 1123^.67 lei
5%

Preț: 1435^.64 lei
20%

Preț: 1044^.10 lei
18%

Preț: 946^.39 lei
5%

Preț: 292^.57 lei
18%

Preț: 957^.62 lei
18%

Preț: 1235^.76 lei
5%

Preț: 1231^.55 lei
5%

Preț: 1292^.30 lei
5%

Preț: 1102^.10 lei
18%

Preț: 1132^.81 lei
5%

Preț: 1165^.19 lei
5%

Preț: 1418^.48 lei
5%

Preț: 1305^.63 lei
18%

Preț: 1417^.72 lei
18%

Preț: 1412^.99 lei
24%

Preț: 806^.15 lei
18%

Preț: 1243^.29 lei
5%

Preț: 1429^.44 lei
5%

Preț: 1618^.70 lei
5%

Preț: 1305^.12 lei
18%

Preț: 1124^.92 lei
5%

Preț: 1097^.54 lei
15%

Preț: 649^.87 lei
5%

Preț: 1097^.54 lei
18%

Preț: 945^.79 lei
5%

Preț: 1123^.13 lei
20%

Preț: 816^.43 lei

Specificații

ISBN-13: 9781493949656
ISBN-10: 1493949659
Pagini: 188
Ilustrații: XXI, 188 p. 48 illus., 2 illus. in color.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.3 kg
Ediția:Softcover reprint of the original 1st ed. 2014
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology

Locul publicării:New York, NY, United States

Cuprins

A20—A Bipartite Ubiquitin Editing Enzyme with Immunoregulatory Potential.- The Biology of A20-Binding Inhibitors of NF- κB Activation (Abins).- The Biology of A20-Like Molecules.- Anti-Viral Tetris: Modulation of the Innate Anti-Viral Immune Response by A20.- A20 Expressing Tumors and Anticancer Drug Resistance.- Translational Studies of A20 in Atherosclerosis and Cardiovascular Disease.- A Biomarker of Allograft Outcome: A Showcase in Kidney Transplantation.- A20—An Omnipotent Protein in the Liver: Prometheus Myth Resolved?.- Emerging Roles for A20 in Islet Biology and Pathology.- Single Nucleotide Polymorphisms at the TNFAIP3/A20 Locus and Susceptibility/Resistance to Inflammatory and Autoimmune Diseases.

Notă biografică

Christiane Ferran, born in Beirut Lebanon, is Professor of Surgery at Harvard Medical School, Boston, Massachusetts, United States of America. She also holds an appointment as Staff Physician in the Division of Nephrology, Department of Medicine and as a Principal Research Investigator in the Division of Vascular Surgery at the Beth Israel Deaconess Medical Center (BIDMC). At BIDMC, Dr. Ferran is an active senior member of the Center for Vascular Biology Research, where she served as the chair of the Junior Faculty Mentoring Committee and of the Transplant Institute. She also chairs the Affinity Research Collaborative, an initiative aimed at fostering collaborative, interdisciplinary research program in the Department of Surgery. Main research interests include deciphering the physiologic molecular response to inflammation and how this response impacts disease pathophysiology, namely vascular diseases, allograft rejection, liver and islet regenerative processes and cellular metabolism. For the past two decades, this endeavor has mainly focused on the potent NF‑kB inhibitory protein, A20, for which she has continuously received external funding, starting in 1996 with a National Institutes of Health (NIH) funded RO1 aimed at studying the role of A20 in endothelial cell biology. Dr. Ferran is a member of numerous National and International Scientific Societies, including the American Society of Transplantation, the International Society of Transplantation, the American Society of Nephrology, the French Society of Nephrology and the American Society of Vascular Surgery. She has served as scientific reviewer on many National Institutes of Health (NIH), juvenile diabetes Research Foundation (JDRF) and Roche Organ Transplant Research Foundation (ROTRF) study sections.